{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,25]],"date-time":"2026-10-25T02:58:11Z","timestamp":1792897091499,"version":"4.5.0"},"reference-count":30,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,11,27]],"date-time":"2024-11-27T00:00:00Z","timestamp":1732665600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gene"],"published-print":{"date-parts":[[2025,2]]},"DOI":"10.1016\/j.gene.2024.149127","type":"journal-article","created":{"date-parts":[[2024,11,28]],"date-time":"2024-11-28T16:45:38Z","timestamp":1732812338000},"page":"149127","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["c.640\u2013814T>C mutation in deep intronic region of alpha-galactosidase A gene is associated with Fabry disease via dominant-negative effect"],"prefix":"10.1016","volume":"936","author":[{"ORCID":"https:\/\/orcid.org\/0009-0002-6931-6196","authenticated-orcid":false,"given":"Piyi","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongxiang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gaxue","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiming","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yonglin","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zixian","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3270-0936","authenticated-orcid":false,"given":"Ming","family":"Bai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"23","key":"10.1016\/j.gene.2024.149127_b0010","doi-asserted-by":"crossref","first-page":"15261","DOI":"10.3390\/ijms232315261","article-title":"Abnormal Pre-mRNA Splicing in Exonic Fabry Disease-Causing GLA Mutations","volume":"23","author":"Alfen","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.gene.2024.149127_b0005","article-title":"Long-term follow-up of renal function in patients treated with migalastat for Fabry disease","volume":"28","author":"Bichet","year":"2021","journal-title":"Mol. Genet. Metab. Rep."},{"issue":"7","key":"10.1016\/j.gene.2024.149127_b0095","doi-asserted-by":"crossref","first-page":"947","DOI":"10.3390\/genes15070947","article-title":"The Missense Variant in the Signal Peptide of \u03b1-GLA Gene, c.13 A\/G, Promotes Endoplasmic Reticular Stress and the Related Pathway\u2019s Activation","volume":"15","author":"Bossio","year":"2024","journal-title":"Genes (Basel)"},{"key":"10.1016\/j.gene.2024.149127_b0015","doi-asserted-by":"crossref","DOI":"10.3390\/ijms19051480","article-title":"Inhibition of arachidonate 12\/15-lipoxygenase improves \u03b1-galactosidase efficacy in iPSC-derived cardiomyocytes from fabry patients","volume":"19","author":"Chien","year":"2018","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.gene.2024.149127_b0020","doi-asserted-by":"crossref","DOI":"10.1136\/openhrt-2021-001815","article-title":"Diagnostic validity and clinical utility of genetic testing for hypertrophic cardiomyopathy: a systematic review and meta-analysis","volume":"9","author":"Christian","year":"2022","journal-title":"Open Heart"},{"key":"10.1016\/j.gene.2024.149127_b0025","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.1016\/j.cca.2010.03.009","article-title":"Newborn screening for Fabry disease by measuring GLA activity using tandem mass spectrometry","volume":"411","author":"Dajnoki","year":"2010","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.gene.2024.149127_b0090","doi-asserted-by":"crossref","first-page":"829312","DOI":"10.3389\/fchem.2022.829312","article-title":"Molecular Approaches to Protein Dimerization: Opportunities for Supramolecular Chemistry","volume":"10","author":"Dang","year":"2022","journal-title":"Front Chem"},{"key":"10.1016\/j.gene.2024.149127_b0030","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1111\/j.1742-4658.2009.07520.x","article-title":"Alternative splicing: role of pseudoexons in human disease and potential therapeutic strategies","volume":"277","author":"Dhir","year":"2010","journal-title":"FEBS J."},{"key":"10.1016\/j.gene.2024.149127_b0035","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1016\/j.jacc.2016.05.090","article-title":"Genetic screening of anderson-fabry disease in probands referred from multispecialty clinics","volume":"68","author":"Favalli","year":"2016","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.gene.2024.149127_b0040","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.jmb.2004.01.035","article-title":"The molecular defect leading to Fabry disease: structure of human alpha-galactosidase","volume":"337","author":"Garman","year":"2004","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.gene.2024.149127_b0045","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/1750-1172-5-30","article-title":"Fabry disease","volume":"5","author":"Germain","year":"2010","journal-title":"Orphanet J. Rare Dis."},{"key":"10.1016\/j.gene.2024.149127_b0050","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1086\/339431","article-title":"Alternative splicing in the alpha-galactosidase A gene: increased exon inclusion results in the Fabry cardiac phenotype","volume":"70","author":"Ishii","year":"2002","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.gene.2024.149127_b0055","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1093\/ehjci\/jew187","article-title":"Insight into hypertrophied hearts: a cardiovascular magnetic resonance study of papillary muscle mass and T1 mapping","volume":"18","author":"Kozor","year":"2017","journal-title":"Eur. Heart J. Cardiovasc. Imaging"},{"key":"10.1016\/j.gene.2024.149127_b0060","doi-asserted-by":"crossref","first-page":"1743","DOI":"10.1021\/ac303033v","article-title":"Multiplex analysis of novel urinary lyso-Gb3-related biomarkers for Fabry disease by tandem mass spectrometry","volume":"85","author":"Lavoie","year":"2013","journal-title":"Anal. Chem."},{"key":"10.1016\/j.gene.2024.149127_b0065","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1093\/ndt\/gfab038","article-title":"Precision medicine in Fabry disease","volume":"36","author":"Lenders","year":"2021","journal-title":"Nephrol. Dial. Transplant."},{"key":"10.1016\/j.gene.2024.149127_b0070","doi-asserted-by":"crossref","DOI":"10.1080\/19490976.2022.2027852","article-title":"Fabry disease - a multisystemic disease with gastrointestinal manifestations","volume":"14","author":"Lenders","year":"2022","journal-title":"Gut Microbes"},{"key":"10.1016\/j.gene.2024.149127_b0075","doi-asserted-by":"crossref","first-page":"e864","DOI":"10.1002\/mgg3.864","article-title":"Functional evaluation of a novel GLA causative mutation in Fabry disease","volume":"7","author":"Li","year":"2019","journal-title":"Mol. Genet. Genomic Med."},{"key":"10.1016\/j.gene.2024.149127_b0080","doi-asserted-by":"crossref","first-page":"60","DOI":"10.3389\/fgene.2019.00060","article-title":"A Novel \u03b1-galactosidase A splicing mutation predisposes to fabry disease","volume":"10","author":"Li","year":"2019","journal-title":"Front. Genet."},{"key":"10.1016\/j.gene.2024.149127_b0085","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1080\/15476286.2019.1676115","article-title":"Translational readthrough of GLA nonsense mutations suggests dominant-negative effects exerted by the interaction of wild-type and missense variants","volume":"17","author":"Lombardi","year":"2020","journal-title":"RNA Biol."},{"key":"10.1016\/j.gene.2024.149127_b0100","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1186\/1532-429X-15-92","article-title":"Myocardial T1 mapping and extracellular volume quantification: a Society for Cardiovascular Magnetic Resonance (SCMR) and CMR working group of the european society of cardiology consensus statement","volume":"15","author":"Moon","year":"2013","journal-title":"J. Cardiovasc. Magn. Reson."},{"key":"10.1016\/j.gene.2024.149127_b0105","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/j.amjcard.2011.09.052","article-title":"Value of electrocardiogram in the differentiation of hypertensive heart disease, hypertrophic cardiomyopathy, aortic stenosis, amyloidosis, and Fabry disease","volume":"109","author":"Namdar","year":"2012","journal-title":"Am. J. Cardiol."},{"key":"10.1016\/j.gene.2024.149127_b0110","doi-asserted-by":"crossref","first-page":"1978","DOI":"10.1161\/01.CIR.0000061952.27445.A0","article-title":"Early detection of Fabry cardiomyopathy by tissue Doppler imaging","volume":"107","author":"Pieroni","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.gene.2024.149127_b0115","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1146\/annurev-genet-111212-133424","article-title":"Organizing principles of mammalian nonsense-mediated mRNA decay","volume":"47","author":"Popp","year":"2013","journal-title":"Annu. Rev. Genet."},{"key":"10.1016\/j.gene.2024.149127_b0120","first-page":"741","article-title":"Plasma globotriaosylsphingosine: diagnostic value and relation to clinical manifestations of Fabry disease","volume":"1802","author":"Rombach","year":"2010","journal-title":"BBA"},{"key":"10.1016\/j.gene.2024.149127_b0125","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1007\/s00439-017-1809-4","article-title":"Deep intronic mutations and human disease","volume":"136","author":"Vaz-Drago","year":"2017","journal-title":"Hum. Genet."},{"key":"10.1016\/j.gene.2024.149127_b0130","doi-asserted-by":"crossref","first-page":"3843","DOI":"10.1105\/tpc.107.055053","article-title":"Exploring the molecular etiology of dominant-negative mutations","volume":"19","author":"Veitia","year":"2007","journal-title":"Plant Cell"},{"key":"10.1016\/j.gene.2024.149127_b0135","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2022.993024","article-title":"Case report: a case of isolated cardiac sarcoidosis diagnosed by multimodal imaging and endomyocardial biopsy","volume":"9","author":"Wa","year":"2022","journal-title":"Front. Cardiovasc. Med."},{"key":"10.1016\/j.gene.2024.149127_b0140","doi-asserted-by":"crossref","first-page":"e2216","DOI":"10.1002\/mgg3.2216","article-title":"Identification and functional analysis of a novel de novo missense mutation located in the initiation codon of LAMP2 associated with early onset female Danon disease","volume":"11","author":"Wang","year":"2023","journal-title":"Mol. Genet. Genomic Med."},{"key":"10.1016\/j.gene.2024.149127_b0145","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1093\/eurheartj\/ehs166","article-title":"Left ventricular hypertrophy in Fabry disease: a practical approach to diagnosis","volume":"34","author":"Yousef","year":"2013","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.gene.2024.149127_b0150","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1016\/S0140-6736(08)61589-5","article-title":"Fabry's disease","volume":"372","author":"Zarate","year":"2008","journal-title":"Lancet"}],"container-title":["Gene"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378111924010084?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378111924010084?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,12,9]],"date-time":"2024-12-09T01:07:16Z","timestamp":1733706436000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0378111924010084"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2]]},"references-count":30,"alternative-id":["S0378111924010084"],"URL":"https:\/\/doi.org\/10.1016\/j.gene.2024.149127","relation":{},"ISSN":["0378-1119"],"issn-type":[{"value":"0378-1119","type":"print"}],"subject":[],"published":{"date-parts":[[2025,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"c.640\u2013814T>C mutation in deep intronic region of alpha-galactosidase A gene is associated with Fabry disease via dominant-negative effect","name":"articletitle","label":"Article Title"},{"value":"Gene","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.gene.2024.149127","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"149127"}}